Yahoo Web Search

Search results

  1. Orano Med seeks to develop a new generation of targeted therapies against cancer using the unique properties of lead-212 (212Pb), a rare alpha-emitting radioisotope and one of the most potent therapeutic payloads against cancer cells.

    • Technology

      Orano Med has a unique position in the field of TAT using...

    • About Us

      Orano Med seeks to develop a new generation of targeted...

    • Contact Us

      Contact Us - Orano Med | Home

    • Pipeline

      Based on the unique properties of 212Pb, Orano Med is...

  2. People also ask

  3. Nuclear Medicine against cancer Orano is at the forefront of research in nuclear medicine and is developing new radioisotopic therapies against cancer. In 2014, Orano Med established a Lead-212 production facility in Plano, Texas. Uranium Sales & Services Orano offers an array of customizable services spanning the entire uranium life cycle.

    • orano med1
    • orano med2
    • orano med3
    • orano med4
    • orano med5
  4. Feb 2, 2024 · Orano Med, a subsidiary of the Orano Group, is a clinical-stage biotechnology company developing a new generation of targeted therapies against cancer using the unique properties of lead-212 (212 ...

  5. Orano Med, based in Texas, is developing cancer-fighting isotopes for radioimmunotherapy, with research progressing for the next phase of FDA approval.

  6. www.linkedin.com › company › orano-medOrano Med | LinkedIn

    Orano Med Biotechnology Research Plano, TX 5,423 followers Innovative targeted alpha therapy to fight cancer using lead-212 (Pb-212) See jobs Follow View all 120 employees About us Based on an...

  1. People also search for